Canine Addisons Disease: Welfare Management and Quality of Life in 2026

Addisons disease (hypoadrenocorticism) is a potentially life-threatening but highly manageable endocrine condition in dogs, with welfare outcomes entirely dependent on correct diagnosis and long-term monitoring.

Key Facts

Addisons disease is caused by destruction of the adrenal cortex, reducing cortisol and aldosterone production
Young to middle-aged female dogs are most commonly affected, with Standard Poodles and Portuguese Water Dogs at elevated risk
Addisonian crisis — acute collapse from electrolyte imbalance — is a veterinary emergency requiring immediate IV treatment
Once stabilised, most dogs have excellent long-term welfare with DOCP injections and oral prednisolone

Welfare Considerations

Addisons disease causes episodes of lethargy, vomiting, weakness, and acute collapse that are severely distressing and life-threatening before diagnosis. The condition is called the great pretender because its non-specific signs can delay recognition for months, during which dogs experience recurring welfare compromise. Once correctly diagnosed and treated with mineralocorticoid replacement, welfare is typically excellent. Long-term management requires periodic monitoring and dose adjustment around stressful events. Dogs well-managed for Addisons disease can enjoy normal quality of life. Early recognition is the critical welfare determinant.

What You Can Do

Consider Addisons disease in any young dog with recurrent vomiting, lethargy, or weakness — request electrolyte testing
Ensure diagnosed dogs receive DOCP injections at appropriate intervals and carry a crisis card for emergency vets
Stress dose prednisolone appropriately for any stressful events in Addisons-affected dogs
Support breeding health testing in predisposed breeds to identify and reduce disease prevalence